1-methylpyridinium has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calabriso, N; Carluccio, MA; Damiano, F; De Caterina, R; Del Rio, D; Favari, C; Massaro, M; Mena, P; Quarta, S; Santarpino, G; Scoditti, E; Siculella, L; Verri, T; Wabitsch, M | 1 |
| Kolodziejczyk, AM; Szymonski, M; Targosz-Korecka, M | 1 |
2 other study(ies) available for 1-methylpyridinium and Innate Inflammatory Response
| Article | Year |
|---|---|
Coffee Bioactive
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Coffee; Diabetes Mellitus; Glucose; Humans; Inflammation; Insulin; Insulin Resistance; Metabolic Syndrome; Mice; Obesity; Pyridinium Compounds; Tumor Necrosis Factor-alpha | 2021 |
Nanomechanical testing of drug activities at the cellular level: Case study for endothelium-targeted drugs.
Topics: Actins; Anti-Inflammatory Agents; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Elasticity; Endothelial Cells; Endothelium, Vascular; Humans; Inflammation; Microscopy, Atomic Force; Microvessels; Prospective Studies; Pyridinium Compounds; Simvastatin; Tumor Necrosis Factor-alpha | 2017 |